The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis

被引:85
作者
Fries, JF [1 ]
Murtagh, KN [1 ]
Bennett, M [1 ]
Zatarain, E [1 ]
Lingala, B [1 ]
Bruce, B [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 08期
关键词
D O I
10.1002/art.20440
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Nonsteroidal antiinflammatory drug (NSAID)-associated gastropathy is a major cause of hospitalization and death. This study was undertaken to examine whether recent preventive approaches have been associated with a declining incidence of NSAID gastropathy, and, if so, what measures may have caused the decline. Methods. We studied 5,598 patients with rheumatoid arthritis (RA) over 31,262 patient-years at 8 sites. We obtained standardized longitudinal information on the patients that had been previously used to establish the incidence of NSAID gastropathy, and also information on patient risk factors and differences in toxicity between NSAIDs. Consecutive patients were followed up with biannual Health Assessment Questionnaires and medical record audits between 1981 and 2000. The major outcome measure was the annual rate of hospitalization involving bleeding, obstruction, or perforation of the gastrointestinal (GI) tract and related conditions. Results. Rates of GI-related hospitalizations rose from 0.6% in 1981 to 1.5% in 1992 (P < 0.001), and then declined to 0.5% in 2000 (P < 0.001). The fitted spline curve fit the data well (R-2 = 0.70). The period of rise was mainly associated with increasing patient age and the GI risk propensity score. The period of decline was associated with lower doses of ibuprofen and aspirin, a decline in the use of "more toxic" NSAIDs from 52% to 42% of patients, a rise in the use of "safer" NSAIDs from 19% to 48% of patients, and increasing use of proton-pump inhibitors, but not with change in age, NSAID exposure, or GI risk propensity score. Conclusion. The risk of serious NSAID gastropathy has declined by 67% in these cohorts since 1992. We estimate that 24% of this decline was the result of lower doses of NSAIDs, while 18% was associated with the use of proton-pump inhibitors and 14% with the use of less toxic NSAIDs. These declines in the incidence of NSAID gastropathy are likely to continue.
引用
收藏
页码:2433 / 2440
页数:8
相关论文
共 41 条
  • [1] NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND LIFE THREATENING COMPLICATIONS OF PEPTIC-ULCERATION
    ARMSTRONG, CP
    BLOWER, AL
    [J]. GUT, 1987, 28 (05) : 527 - 532
  • [2] Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale
    Berg, AO
    Allan, JD
    Frame, PS
    Homer, CJ
    Johnson, MS
    Klein, JD
    Lieu, TA
    Mulrow, CD
    Orleans, CT
    Peipert, JF
    Pender, NJ
    Siu, AL
    Teutsch, SM
    Westhoff, C
    Woolf, SH
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) : 157 - 160
  • [3] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    Day, R
    Ferraz, MB
    Hawkey, CJ
    Hochberg, MC
    Kvien, TK
    Schnitzer, TJ
    Weaver, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
  • [4] BROOKS PM, 1991, NEW ENGL J MED, V324, P1716
  • [5] Bruce B, 2003, J RHEUMATOL, V30, P167
  • [6] Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen
    Chan, FKL
    Chung, SCS
    Suen, BY
    Lee, YT
    Leung, WK
    Leung, VKS
    Wu, JCY
    Lau, JYW
    Hui, Y
    Lai, MS
    Chan, HLY
    Sung, JJY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) : 967 - 973
  • [7] Douthwaite AH, 1938, LANCET, V2, P1222
  • [8] MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS
    FRIES, JF
    SPITZ, P
    KRAINES, RG
    HOLMAN, HR
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (02): : 137 - 145
  • [9] TOWARD AN EPIDEMIOLOGY OF GASTROPATHY ASSOCIATED WITH NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE
    FRIES, JF
    MILLER, SR
    SPITZ, PW
    WILLIAMS, CA
    HUBERT, HB
    BLOCH, DA
    [J]. GASTROENTEROLOGY, 1989, 96 (02) : 647 - 655
  • [10] FRIES JF, 1990, J RHEUMATOL, V17, P12